Lasix Onyufurosemide

According to the FDA label: Lasix ONYU is a loop diuretic indicated for the treatment of edema in adult patients with chronic heart failure. ( 1.1 ) 1.1 Congestion Lasix ONYU is indicated for the treatment of edema in adult patients with chronic heart failure.

257,086 adverse event reports submitted to the FDA (1998–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Lasix Onyu in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Lasix Onyu adverse event reports by reporter sex
SexReports
Female128,528
Male108,964
Unknown335

By Age Group

View age group data as a table
Lasix Onyu adverse event reports by reporter age group
Age groupReports
0-174,790
18-344,700
35-4912,548
50-6441,836
65-7449,735
75+74,822

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Lasix Onyu. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Lasix Onyu adverse event reports by reported outcome
OutcomeReports
Hospitalization126,062
Other Serious118,970
Non-Serious44,079
Death39,822
Life-Threatening18,170
Disability6,800

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Lasix Onyu. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Lasix Onyu adverse event reports by year
YearReports
19981
20011
20034
20043,477
20053,855
20063,622
20073,211
20083,608
20093,994
20104,836
20116,478
20127,273
20137,405
201410,059
201513,254
201616,200
201716,714
201821,187
201923,003
202020,345
202118,729
202216,299
202316,467
202417,397
202516,121
2026 (partial)3,546

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Lasix Onyu

In FDA adverse event reports that mention Lasix Onyu, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026